Clinical Trial Update: Efficacy and Safety of TMZ Plus 6-MP in the Patients With Recurrent Glioblastoma [Phase 1, Phase 2]

View source ↗

Summary

Clinical trial investigating the safety and efficacy of temozolomide (TMZ) plus 6-mercaptopurine (6-MP) in patients with recurrent glioblastoma, spanning Phase …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Glioblastoma

Drugs mentioned

• 6-mercaptopurine (6-mercaptopurine)
• Temozolomide (Temozolomide)

Snippet

Sponsor: The First Affiliated Hospital with Nanjing Medical University | Conditions: Glioblastoma, Cancer | Phase 1, Phase 2 | Status: UNKNOWN